According to a recent study, White rosacea patients have an increased risk for malignant melanoma than non-White patients.
Study suggests significant autoimmune disease prevalence in PsO patients
According to a recent study, there is a significant autoimmune disease prevalence in psoriasis patients.
Fixed-dose, triple-combination gel efficacious, safe in moderate-to-severe acne patients
According to a recent study, a fixed-dose, triple-combination of clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% (CAB) topical formulation demonstrated efficacy and safety in both adult and pediatric patients with moderate-to-severe acne.
Impaired mobility in AD patients linked to sex and age
According to a recent study, atopic dermatitis (AD) patients have an increased risk of impaired mobility if they are male or aged 40 to 59 years.
High sodium intake associated with increased risk of AD
According to a recent study, high sodium intake is linked to an increased risk of atopic dermatitis (AD) and AD severity.
HS patients at increased risk of anxiety disorders
According to a recent study, patients with hidradenitis suppurativa (HS) are at an increased risk of anxiety disorders such as phobic disorders, panic disorder, generalized anxiety disorder or unspecified anxiety.
Isotretinoin efficacious in treating transgender patients receiving gender-affirming treatment
According to a recent study, isotretinoin is effective and well tolerated in transgender individuals with acne receiving masculinizing gender-affirming hormonal therapy.
Older patients on antihypertensive medications at increased risk of eczematous dermatitis
According to a recent study, older adults taking antihypertensive drugs are at an increased risk of eczematous dermatitis.
Crisaborole efficacious long-term in treating mild-to-moderate AD
According to a recent study, daily crisaborole ointment was efficiacious in treating mild-to-moderate atopic dermatitits (AD) long-term.
Tildrakizumab efficacious in treating scalp psoriasis
According to a recent study, tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.
HealthMinute.TV 